Cite
HARVARD Citation
Peyrade, F. et al. (2017). Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group. Lancet. 4 (1), pp. e46-e55. [Online].